Failure to discount for conflict of interest when evaluating medical literature: a randomised trial of physicians
Authors:
- 6 May 2010
- journal article
- research article
- Published by BMJ in Journal of Medical Ethics
- Vol. 36 (5) , 265-270
Abstract
Context Physicians are regularly confronted with research that is funded or presented by industry. Objective To assess whether physicians discount for conflicts of interest when weighing evidence for prescribing a new drug. Design and setting Participants were presented with an abstract from a single clinical trial finding positive results for a fictitious new drug. Physicians were randomly assigned one version of a hypothetical scenario, which varied on conflict of interest: ‘presenter conflict’, ‘researcher conflict’ and ‘no conflict’. Participants 515 randomly selected Fellows in the American College of Obstetricians and Gynecologists' Collaborative Ambulatory Research Network; 253 surveys (49%) were returned. Main object measures The self-reported likelihood that physicians would prescribe the new drug as a first-line therapy. Results Physicians do not significantly discount for conflicts of interest in their self-reported likelihood of prescribing the new drug after reading the single abstract and scenario. However, when asked explicitly to compare conflict and no conflict, 69% report that they would discount for researcher conflict and 57% report that they would discount for presenter conflict. When asked to guess how favourable the results of this study were towards the new drug, compared with the other trials published so far, their perceptions were not significantly influenced by conflict of interest information. Conclusion While physicians believe that they should discount the value of information from conflicted sources, they did not do so in the absence of a direct comparison between two studies. This brings into question the effectiveness of merely disclosing the funding sources of published studies.Keywords
This publication has 22 references indexed in Scilit:
- Physicians and Drug Representatives: Exploring the Dynamics of the RelationshipJournal of General Internal Medicine, 2007
- Medical Students’ Exposure to and Attitudes About Drug Company InteractionsJAMA, 2005
- Association of Funding and Conclusions in Randomized Drug TrialsJAMA, 2003
- Scope and Impact of Financial Conflicts of Interest in Biomedical ResearchJAMA, 2003
- Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trialAlimentary Pharmacology & Therapeutics, 2000
- Preference reversals between joint and separate evaluations of options: A review and theoretical analysis.Psychological Bulletin, 1999
- The Accuracy of Drug Information From Pharmaceutical Sales RepresentativesJAMA, 1995
- Mental contamination and mental correction: Unwanted influences on judgments and evaluations.Psychological Bulletin, 1994
- The Curse of Knowledge in Economic Settings: An Experimental AnalysisJournal of Political Economy, 1989
- Perseverance in self-perception and social perception: Biased attributional processes in the debriefing paradigm.Journal of Personality and Social Psychology, 1975